AMG National Trust Bank Has $525,000 Position in The Clorox Company (NYSE:CLX)

AMG National Trust Bank cut its holdings in The Clorox Company (NYSE:CLX - Free Report) by 55.7% in the 3rd quarter, according to its most recent 13F filing with the SEC. The fund owned 3,225 shares of the company's stock after selling 4,050 shares during the period. AMG National Trust Bank's holdings in Clorox were worth $525,000 at the end of the most recent reporting period.

Several other institutional investors also recently bought and sold shares of the business. Innealta Capital LLC acquired a new stake in shares of Clorox during the 2nd quarter worth $30,000. Trifecta Capital Advisors LLC increased its holdings in Clorox by 139.8% in the 2nd quarter. Trifecta Capital Advisors LLC now owns 223 shares of the company's stock valued at $30,000 after purchasing an additional 130 shares in the last quarter. Quarry LP boosted its position in Clorox by 99.1% in the 2nd quarter. Quarry LP now owns 229 shares of the company's stock valued at $31,000 after buying an additional 114 shares during the last quarter. Family Firm Inc. purchased a new position in Clorox in the 2nd quarter valued at about $31,000. Finally, EntryPoint Capital LLC purchased a new position in Clorox in the 1st quarter valued at about $39,000. 78.53% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

CLX has been the subject of a number of analyst reports. Evercore ISI decreased their price objective on shares of Clorox from $140.00 to $139.00 and set an "underperform" rating for the company in a research report on Monday, October 14th. Barclays increased their price target on shares of Clorox from $137.00 to $139.00 and gave the stock an "underweight" rating in a research report on Friday, November 1st. Citigroup increased their price target on shares of Clorox from $165.00 to $170.00 and gave the stock a "neutral" rating in a research report on Friday, September 6th. Deutsche Bank Aktiengesellschaft increased their price target on shares of Clorox from $144.00 to $151.00 and gave the stock a "hold" rating in a research report on Friday, August 2nd. Finally, BNP Paribas raised shares of Clorox to a "strong sell" rating in a research report on Friday, September 6th. Five analysts have rated the stock with a sell rating, ten have assigned a hold rating and one has issued a buy rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Hold" and an average price target of $155.00.

Insider Buying and Selling

In other Clorox news, EVP Angela C. Hilt sold 1,733 shares of Clorox stock in a transaction on Friday, September 6th. The shares were sold at an average price of $165.52, for a total transaction of $286,846.16. Following the completion of the sale, the executive vice president now owns 13,471 shares of the company's stock, valued at $2,229,719.92. This trade represents a 11.40 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Company insiders own 0.57% of the company's stock.

Clorox Price Performance

Shares of NYSE CLX traded down $0.09 during mid-day trading on Wednesday, reaching $168.05. 1,138,983 shares of the company traded hands, compared to its average volume of 1,243,088. The Clorox Company has a fifty-two week low of $127.60 and a fifty-two week high of $169.21. The company has a debt-to-equity ratio of 11.08, a current ratio of 1.00 and a quick ratio of 0.62. The firm has a market cap of $20.80 billion, a PE ratio of 58.59, a price-to-earnings-growth ratio of 3.10 and a beta of 0.41. The stock has a fifty day simple moving average of $162.56 and a 200-day simple moving average of $147.94.

Clorox (NYSE:CLX - Get Free Report) last issued its earnings results on Wednesday, October 30th. The company reported $1.86 earnings per share for the quarter, topping analysts' consensus estimates of $1.36 by $0.50. The firm had revenue of $1.76 billion during the quarter, compared to analysts' expectations of $1.64 billion. Clorox had a net margin of 4.78% and a return on equity of 316.08%. The firm's revenue for the quarter was up 27.0% compared to the same quarter last year. During the same period last year, the firm posted $0.49 earnings per share. Equities research analysts anticipate that The Clorox Company will post 6.85 EPS for the current fiscal year.

Clorox Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Wednesday, January 29th will be paid a $1.22 dividend. This represents a $4.88 dividend on an annualized basis and a yield of 2.90%. The ex-dividend date is Wednesday, January 29th. Clorox's dividend payout ratio is 170.04%.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.